TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive House Committee Allocates NCI $1.347 Billion, $189 Million Over President’s Request For 1987 August 1, 1986
TCL Archive Cancer Patients Satisfied With Experience In Clinical Trials, Survey Of 2,000 Finds July 28, 2006
TCL Archive Audit Finds NIH Conflict of Interest Reports Scattered, Inaccessible, And Incomplete. January 25, 2008
